Month: April 2021

With medical visits picking up again among patients vaccinated against covid-19, health providers are starting to see the consequences of a year of pandemic-delayed preventive and emergency care as they find more advanced cancer and rotting and damaged teeth, among other ailments. Dr. Brian Rah, chair of the cardiology department at Montana’s Billings Clinic, was confused
0 Comments
April 16, 2021 — Today, the U.S. Food and Drug Administration revoked the emergency use authorization (EUA) that allowed for the investigational monoclonal antibody therapy bamlanivimab, when administered alone, to be used for the treatment of mild-to-moderate COVID-19 in adults and certain pediatric patients. Based on its ongoing analysis of emerging scientific data, specifically the
0 Comments
ROUND ROCK, Texas, April 19, 2021 /PRNewswire/ — ALK (ALKB: DC / OMX: ALK B / AKABY / AKBLF), a global, research-driven pharmaceutical company that focuses on the diagnosis and treatment of allergies, announced that the U.S. Food and Drug Administration (FDA) approved Ragwitek (Short Ragweed Pollen Allergen Extract) Tablet for Sublingual Use for the
0 Comments
In this article JNJ A Johnson & Johnson building is shown in Irvine, California. Mike Blake | Reuters Johnson & Johnson on Tuesday reported $100 million in first-quarter sales of its Covid-19 vaccine that’s on hold in the U.S. while U.S. health regulators investigate a rare blood-clotting issue. In releasinging its first-quarter financial results, the
0 Comments
A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing. Vaccines created by UVA Health’s Steven L. Zeichner, MD, PhD, and Virginia Tech’s Xiang-Jin Meng, MD, PhD, prevented pigs from being becoming
0 Comments
Research suggests certain gut bacteria can reduce the efficacy of radiotherapy against cancers, but targeting those bacteria with vancomycin can reverse this effect. Facciabene reviewed this research at the AACR Virtual Special Conference: Radiation Science and Medicine. According to Facciabene, “gut microbiota” includes the more than 1,000 different strains of bacteria living in human intestines.
0 Comments
Last year, the World Health Organisation (WHO) announced an ambitious plan: to create a ‘cervical cancer-free future’. The potential reward is huge. If we succeed, cervical cancer will become the first cancer to be ‘eliminated’ on this scale. But right now, around the world, someone dies every 2 minutes from cervical cancer, with lower resource
0 Comments
PRINCETON, N.J.–(BUSINESS WIRE)– April 16, 2021 Opdivo is the first and only immunotherapy in combination with chemotherapy to deliver superior overall survival versus chemotherapy alone in a trial of this patient population1 U.S. Food and Drug Administration Approves Opdivo® (nivolumab) in Combination with Chemotherapy for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer, and Esophageal Adenocarcinoma, Regardless
0 Comments
April 16, 2021 Audience: Consumers April 16, 2021 — Sanit Technologies LLC d/b/a Durisan announces a voluntary recall expansion of its Durisan Antimicrobial Hand Sanitizer, NonAlcohol products in various sizes listed to now include products that have not yet expired. The products are being recalled due to out of specification microbial contamination. The issue was
0 Comments
Hospitalized COVID-19 patients with acute neurologic syndromes and signs had a much higher risk of death, the Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID) study showed. Mortality was nearly six times higher in hospitalized COVID-19 patients with clinically verified neurologic manifestations than in hospitalized COVID-19 patients with or without neurologic features (OR 5.99,
0 Comments
Cover up and use sunscreen to protect yourself from skin cancer. Sound familiar? Those words of warning should be taken seriously because a certain type of skin cancer called malignant melanoma can kill. How can a tiny mole on your shoulder or leg be so deadly?
0 Comments
The pause on the Johnson & Johnson Covid 19 vaccine should last days, not weeks, according to CDC and FDA officials.  In a 37-minute online briefing Tuesday, government health officials said pausing administering the J&J vaccine will give scientists time to investigate what appears to be an autoimmune response that leads to cerebral venous sinus
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Two new large international studies have found relatively low rates of stroke in patients hospitalized with COVID-19.   One study showed a stroke rate of 2.2% among patients with COVID-19 admitted to intensive care in 52 different countries. Another found a
0 Comments
TARRYTOWN, N.Y., April 12, 2021 /PRNewswire/ — Second Phase 3 trial undertaken in collaboration with NIAID to announce results today, both using subcutaneous administration of REGEN-COV in asymptomatic individuals without prior COVID-19 infection Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive data from a Phase 3 trial (2069B) of recently infected asymptomatic COVID-19 patients, evaluating REGEN-COV™ (casirivimab with
0 Comments
In focused attempts to bring an end to the deadly spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic, two new mRNA vaccines were rolled out after receiving emergency use authorization (EUA) by the US Food and Drugs Administration (FDA). The mRNA vaccines Both
0 Comments
The COVID-19 pandemic was linked with a global decline in the volume of stroke hospitalizations, intravenous thrombolysis (IVT), and interfacility IVT transfers, a researcher reported. From March to June 2020, stroke admissions declined by 11.5% at 457 worldwide centers versus 4 months immediately before the pandemic, according to Thanh Nguyen, MD, of Boston University School
0 Comments